Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma

A 20-year-old woman was diagnosed with stage 4 lung adenocarcinoma with an epidermal growth factor receptor (EGFR) exon 20 insertion gene mutation. Although the patient underwent chemotherapy, her lesions progressed. Liquid biopsy for EGFR T790M mutation showed negative results. After administering...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EXCLI J
Main Authors: Murano, Chihiro, Igarashi, Akira, Yamauchi, Keiko, Inoue, Sumito, Watanabe, Masafumi
Formato: Artigo
Idioma:Inglês
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2019
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6806250/
https://ncbi.nlm.nih.gov/pubmed/31645848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17179/excli2019-1786
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares